Skip to content

A Study to Evaluate the Effectiveness of a Hair Serum for Hair Growth in Healthy Men and Women.

A Clinical Study to Evaluate the Efficacy of the Test Hair Serum in Improving Hair Growth and Associated Hair Benefits in Healthy Male and Female Trial Participants - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113316
Enrollment
38
Registered
2026-07-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Shveta Labs Hair Serum with Ghee and Rose: Topical application of the test hair serum on the scalp with gentle massage for absorption, as per the prescribed regimen Control Intervention

Sponsors

Shveta Labs
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male and Female Trial participants in the age group 35 to 55 years both the ages inclusive. 2. Hair density of greater than or equal to 125 and lesser than or equal to 225 hair follicle per square cm as per TrichoScan measurement. 3. Hair thinning assessment grade between Grade 3 to Grade 6 using photo numerical scale. 4. Trial participants with at least one of the following complaints: dry, damaged hair, brittle and thin hair, hair loss evident while combing or after washing, self-perceived reduced hair density. 5. Trial participants willing to maintain the same hair style, approximate length, and hair color throughout the study. 6. Trial participants willing to undergo shaving of a test area on the scalp and have a mark in the target area

Exclusion criteria

Exclusion criteria: 1. Trial participants who have undergone any kind of hair growth treatment in the last 2 weeks. 2. Trial participants who have undergone hair treatments like smoothing, keratin, cream bath, hair spa, etc. in the last 2 weeks. 3. Trial participants having any active scalp disease which may interfere with the study. 4. Prior use of scalp hair growth treatment e.g., finasteride, minoxidil within 6 months. 5. Trial participants with dandruff or other scalp conditions that require treatment. 6. Trial participants participating in another similar cosmetic or therapeutic trial within the last two weeks

Design outcomes

Primary

MeasureTime frame
1. Change from baseline in hair thinning score, hair density score, and hair pull test score/count as assessed by dermatological evaluation at Day 28, Day 56, and Day 84. 2. Change in anagen to telogen ratio (A/T ratio) from baseline to Day 84 in participants as measured by TrichoScan . 3. Change in hair growth from baseline across all subsequent time points in participants as measured by TrichoScan . 4. Change in hair fall from baseline across all subsequent time points as measured by the standardized hair comb test. 5. Change from baseline in scalp sebum level at Day 28, Day 56, and Day 84, as measured by Sebumeter. 6. Change in hair thickness, as measured by Caselite software, compared to baseline and all defined time pointsTimepoint: D-16, D-14, D0, D2, D28, D30, D56, D58, D84, D86

Secondary

MeasureTime frame
1. Change in perceived hair growth from baseline across all subsequent time points, as evaluated by trial participant self-assessment. 2. Evaluation of the overall safety of the test products.Timepoint: D-16, D-14, D0, D2, D28, D30, D56, D58, D84, D86

Countries

India

Contacts

Public ContactSudhanthiran S

MS Clinical Research Pvt. Ltd

ritambhara@msclinical.com08040917253

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026